• Assistant Adjunct Professor

    Dr. Anderson's  research interests lie at the intersection of public health policy and social cognition.  She investigates marketing strategies that tap implicit constructs of self and perceptions of others, pair brand identities with personal identities, and encourage consumption of products detrimental to individual and public health. 

  • Assistant Adjunct Professor in Clinical Pharmacy

    Research focuses on health policy and tobacco control, particularly the ways that clinical research is translated into policy interventions and public knowledge.

  • Assistant Professor In-Residence of Medicine

    My primary research interest is studying the physiologic and inflammatory mechanisms of airway remodeling in various exposure-response models such as ozone-induced oxidative injury, allergic airway inflammation, and wood or tobacco smoke-induced airway injury.  

  • Prrofessor in Residence

    Dr. Balmes’ laboratory, the Human Exposure Laboratory (HEL), has been studying the respiratory and cardiovascular health effects of various air pollutants for the past 25 years. The HEL is currently investigating the respiratory and cardiovascular effects of secondhand tobacco smoke.

  • Health Sciences Clinical Professor, UCSF School of Pharmacy, Department of Clinical Pharmacy
    Adjunct Assistant Professor of Law, UC Hastings College of the Law

    Research of the tobacco industry documents in the UCSF Legacy Tobacco Documents Library, mentoring other CTCRE researchers, and researching and writing state tobacco control activity reports that explore the reasons for the successes, and the failures, of tobacco control efforts.

  • Professor of Medicine, Bioengineering and Therapeutic Sciences

    Research focuses primarily on the human pharmacology of nicotine and other stimulant drugs.  Dr. Benowitz's laboratory has conducted studies on the disposition kinetics, metabolism and pharmocodynamics of nicotine, with an emphasis on the role of nicotine and maintaining nicotine addiction in causing tobacco-related diseases, including cardiovascular disease and cancer.

  • Associate Professor in Residence, Department of Social Behavioral Sciences

    Dr. Stella Bialous’ research focuses on the WHO Framework Convention on Tobacco Control, tobacco industry monitoring and building nurses’ capacity for tobacco control nationally and internationally. Dr. Bialous has consulted with the World Health Organization’s Tobacco Free Initiative for over 15 years.  In 2003, she received the American Legacy Foundation’s Sybill G.

  • Professor of Medicine, Endowed Chair Occupational and Environmental Medicine

    Paul Blanc is Chief of the Division of Occupational and Environmental Medicine. He has authored numerous scholarly publications on the subject of toxic exposures and illness and is author of How Everyday Products Make People Sick (2009, UC Press).

  • Assistant Vice Chancellor of Library Systems and Instructional Technology, UCSF

    Karen Butter co-leads TCORS Core B - Informatics and Analytics - along with Kevin Delucchi.  The Informatics component of Core B will enrich the Legacy Tobacco Documents Library, the largest single source of information on the tobacco industry.  As part of TCORS marketing and warning labels databases will be added to LTDL to support new approaches to perceptions, beh

  • Assistant Professor of Medicine

    Research focuses on the effects of active and passive smoking on susceptibility to acute lung injury, a major cause of respiratory failure in critically ill patients. In addition, she is interested in the use of biomarkers to measure cigarette smoke exposure.

  • Clinical Professor, Department of Psychiatry

    Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers.

  • Associate Professor, Department of Physiological Nursing - Gerontology/Oncology

    Dr. Cataldo's research and clinical foci include: older adults’ risk perceptions of conventional, new and emerging  tobacco  products, and e- cigarettes, how these perceptions are affected by pro- and anti-tobacco messages; the impact of tobacco industry activities on older smokers and geriatric science; lung cancer stigma, symptom burden, and quality of life; and use of virtual worlds as an mHealth intervention to decrease lung cancer stigma and improve patient-clinician communication.

  • Associate Adjunct Professor, UCSF School of Dentistry

    Dr. Cheng earned her medical degree in China, M.S. in nutrition at Cornell University in 2002, and Ph.D. in biostatistics at the University of Pennsylvania in 2006. Before joining UCSF School of Dentistry in 2010, Dr. Cheng was an Assistant Professor in Biostatistics at the University of Florida’s College of Medicine.

  • Professor of Clinical Pharmacy

    Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.  

  • Professor of Biostatistics in Psychiatry

    Dr. Delucchi is a quantitative expert specializing in psycho-social research.

  • Professor, School of Dentistry

    My research concentrates on oral health research, health disparities research, applied statistical analyses and related method­ological issues. Balancing these components is essential to successful and practical oral epidemiology research.

  • Professor in Residence, Cardiology, San Francisco General Hospital

    Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research.

  • Professor of Medicine

    Dr. Glantz, the Truth Initiative Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. Dr.

  • Professor of Medicine

    Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function.

  • Associate Professor of Pharmacy and Medicine

    The overall goal of my research group is to identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response (pharmacogenetics). In addition, we are interested in how racially-specific genetic diffs. modify disease and response to treatment.

  • Professor of Epidemiology and Biostatistics

    Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based.

  • Professor in Residence

    Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence.

  • Professor in Residence, Psychiatry

    Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.

  • Professor of Environmental Health Sciences, UC Berkeley

    Research focuses on exposure assessment as it relates to human health; within this broad category there are three major foci: occupational health, environmental health, and secondhand smoke.

  • Professor

    Primarily focused on cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants. 

  • Professor of Clinical Pharmacy

    Interests in tobacco cessation education and training of health professionals. She has co-coordinated, with other Tobacco Center members (Drs. Corelli and Hudmon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for health professional students and practitioners. She practices at the UCSF adult diabetes and primary care clinics, where she provides smoking cessation counseling. She also is a member of the UCSF Tobacco Education Center, where she provides medication therapy information and advice during their group cessation classes.

  • Associate Adjunct Professor.

    Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws.

  • Professor of Medicine

    Dr. Ling studies tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless and novel tobacco product marketing strategies.  She also studies how to use tobacco industry marketing strategies to improve tobacco control programs.

  • Professor and Chair, Department of Social & Behavioral Sciences

    Research focuses on tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.

  • Associate Clinical Professor, Department of Pediatrics

    Dr. Marbin's research interests focus on the impact of tobacco on low income, urban children and reducing the burden of secondhand smoke on children. Specifically, designs and implements trainings for pediatricians to help them address smoking in low income urban populations. She is also studying the impact of electronic health record changes on clinical uptake of tobacco cessation interventions, as well as the use of online trainings to train physicians on smoking cessation.

  • Professor of Medicine and Anesthesia at the University of California at San Francisco
    Director of the Critical Care Medicine Training in the Department of Medicine and Associate Director of the Intensive Care Unit

    Michael A. Matthay, MD is a Professor of Medicine and Anesthesia at the University of California at San and a Senior Associate at the Cardiovascular Research Institute. He is Associate Director of the Intensive Care Unit.  He received his AB from Harvard University in 1969 and his MD from the University of Pennsylvania School of Medicine in 1973. Dr.

  • Professor In Residence

    Research focuses on the economic impact of tobacco on health and healthcare expenditures.  Dr. Max and her colleagues have worked for over two decades to develop models to estimate the  costs associated with smoking and exposure to secondhand smoke.    

  • UCSF Professor of Radiology and Biomedical Imaging
    Director, Substance Abuse Neuroimaging DVA Medical Center Center for Imaging of Neurodegenerative Diseases (CIND)
    Co-Director, San Francisco Treatment Research Center School of Medicine, UCSF

    Dr. Meyerhoff is Professor in Residence at UCSF, Senior Researcher at the San Francisco Veterans Affairs Medical Center, and Co-Director of the Treatment Research Center at the Department of Psychiatry, UCSF.  Dr. Meyerhoff completed his undergraduate degree in Physics and his Dr.rer.nat. (PhD equivalent) in Chemistry at the Westphaelische-Wilhelms-Universitaet in Muenster, Germany. His two-year postdoctoral fellowship at the University of California, Berkeley in the Department of Chemistry focused on two-dimensional high-resolution NMR spectroscopy.

  • Professor of Clinical Medicine

    Dr. Nguyen is Professor of  Clinical Medicine at UCSF, where he provides primary care to a diverse patient population and teaches students, clinicians, and researchers. He is the Co-Director of the Vietnamese Community Health Promotion Project, a community-academic research unit working on Asian health issues since 1986.  Dr. Nguyen’s research focuses on addressing health disparities using community-based participatory research (CBPR) methods. Dr.

  • Assistant Professor in Residence

    Dr. Danielle Ramo is Assistant Professor and licensed psychologist in the Department of Psychiatry and the Helen Diller Family Comprehensive Cancer Center at UCSF . She directs the Research on Addictions and Digital Interventions ("Readi") lab (readi.ucsf.edu). Her research program focuses on using digital media to change health risk behaviors including tobacco, alcohol, and other drug involvement. Funded with a K23 Career Development Award from the National Institute on Drug Abuse, Dr.

  • Professor

    Dr. Rita Redberg is a cardiologist, and directs women’s cardiovascular services and the UCSF Flight Attendant Clinic. Her research interests are in the effects of secondhand smoke and other work related conditions (radiation) on flight attendants, as well as in technology assessment and preventive cardiology.

  • Professor

    Research program centers on the development of nicotine dependence in adolescents.

  • Assistant Clinical Professor, Division of Hospital Medicine

    Sujatha Sankaran is an Assistant Professor of Medicine with the Division of Hospital Medicine. She received her medical degree from the University of Southern California Keck School of Medicine and subsequently completed her training in Internal Medicine at the Georgetown Universty/Washington Hospital Center program in June 2005. She then worked as an Academic Hospitalist at Columbia University in New York City, where she was actively involved in resident education.

  • Professor of Clinical Medicine, UCSF

    Dr. Satterfield’s research primarily focuses on the implementation of evidence-based behavioral interventions in primary care including screening, brief interventions, and behaviorally-based treatments for tobacco and substance use disorders.  His group is actively testing electronic and mobile health technologies as potential tools to extend clinician reach, improve access, and enhance treatment fidelity.  

  • Assistant Adjunct Professor of Medicine

    Dr. Suzaynn Schick studies the effects of exposure to secondhand cigarette smoke on the upper and lower respiratory tract in human subjects and the chemical and physical changes that occur in aging secondhand smoke.  Dr. Schick received her BS in Cell and Molecular Biology and the University of Washington and her PhD in Biomedical Sciences at the University of California, San Francisco.  She did postdoctoral training under Professors Stan Glantz and John Balmes and now leads her own group in the Human Exposure Laboratory at San Francisco General Hospital campus. 

  • Distinguished Professor of Health and Health Care

    Research focuses on determinants of medical expenditures, efficacy of medical cost containment, quality of care, and tobacco control with an emphasis on smoking cessation.  

  • Professor of Clinical Medicine

    Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.   

  • Associate Adjunct Professor

    Research has focused on "legitimate" tobacco industry activities, and tobacco industry relationships with other groups.  

  • Assistant Professor, University of California, Merced School of Social Sciences, Humanities, and Arts

    Dr. Song is a health psychologist who studies adolescent and young adult decision-making processes underlying smoking behaviors. Her research focuses on ethnic/class disparities, smoking-related perceptions, and personality and socio-cognitive factors that shape smoking-related attitudes.

  • Professor of Medicine

    Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his Ph.D. from Stanford University in 1992.  He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of two non-clinicians on the faculty of the Division of Cardiology.  The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.   

  • Assistant Professor of Medicine, Division of Clinical Pharmacology, Dept. of Medicine

    The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.

  • Adjunct Professor, Institute for Health & Aging

    Research focuses on costs of smoking, costs of illness, evaluation of the economic impact of tobacco taxation and other tobacco control policies, secondhand smoke exposure, and cancer screening and outcomes.

  • Associate Adjunct Professor

    Research program focuses on smoking cessation treatment in special populations including Asian Americans, and clients in substance abuse treatment. She is interested in the use of social network and support in promoting utilization of and delivering evidence-based treatment in underserved populations.   

  • Assistant Professor in Residence

    My research focuses on tobacco use in vulnerable populations, with a particular emphasis on interventions with the homeless population. My population-based research includes the analysis of cross-sectional and longitudinal data, including the analysis of national data, to examine the use of novel tobacco products and the efficacy of tobacco control policies on reducing tobacco use in low-income populations.

  • Assistant Professor of Health Economics

    Dr. Justin White is a health economist with joint appointments in the Philip R. Lee Institute for Health Policy Studies and the Department of Epidemiology and Biostatistics. He studies how monetary and social incentives can be used to promote healthy behavior, informed by research from the field of behavioral economics. Much of his work focuses on chronic disease prevention, notably smoking cessation, in low- and middle-income countries.

  • Assistant Professor of Medicine in Residence

    Research program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network.

  • Associate Professor

    Dr. Yerger's research focuses on the tobacco industry’s targeting of African American communities, the use of menthol in tobacco products, smoke-free policies in multi-unit housing.